NEWS Life Molecular Imaging announces presentation of new scientific data at the Alzheimer’s Association International Conference 29 July 2022 LEARN MORE
NEWS Life Molecular Imaging and BIOKOSMOS SA Announce a Strategic Partnership for the Production and Supply of Neuraceq® in Greece, Bulgaria, North Macedonia and Albania 15th July 2022 LEARN MORE
NEWS Life Molecular Imaging and R2IBF Announce the First Commercial PET Scan of Florbetaben (18F) in Brazil May 31, 2022 LEARN MORE
NEWS DuChemBio Co., Ltd. & Life Molecular Imaging Announce Material Transfer And Clinical Supply Agreement for [18F]PI-2620 Tau PET Tracer August 17, 2021 LEARN MORE
NEWS Life Molecular Imaging Receives Orphan Drug Designations for its Tau Tracer PI-2620 as Diagnostic Tool for Progressive Supranuclear Palsy and Corticobasal Degeneration May 20, 2021 LEARN MORE
NEWS Life Molecular Imaging announces an ongoing collaboration with UCB forPI-2620, a novel tau imaging agent, for improved diagnosis of ProgressiveSupranuclear Palsy March 3, 2021 LEARN MORE
NEWS Life Molecular Imaging is Proud to Support the New IDEAS Study to FurtherDemonstrate the Value of Amyloid PET for Diagnosing Alzheimer’s Diseasein Diverse Communities December 11, 2020 LEARN MORE
NEWS Tau-PET Tracer PI-2620 Could Set New Standards for an Improved Diagnosis of Progressive Supranuclear Palsy July 7, 2020 LEARN MORE
NEWS Life Molecular Imaging announces presentation of new scientific data at the Human Amyloid Imaging Meeting Januray 15, 2020 LEARN MORE
